Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03913988 · ClinicalTrials.gov registry record · NA

Comparative Effectiveness of Three Lucid Dreaming and Sleep Hygiene Techniques

A NA study, sponsored by Columbia University.

Completed
Registry status
NA
Development phase
28
Enrollment target

NCT03913988: Completed NA study, sponsored by Columbia University.

NCT03913988 is a NA study that has completed, run by Columbia University. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03913988, a NA study, has completed, sponsored by Columbia University.

COMPLETED
Registry status
NA
Development phase
28 participants
Enrollment target

Study Summary

In this study, the investigators will compare traditional lucid dream induction techniques, stress reduction strategies, and sleep hygiene across three study groups: (1) lucid dream and stress reduction techniques, and sleep hygiene; (2) lucid dream reduction and sleep hygiene; and (3) sleep hygiene. Participants will be first-year occupational therapy students embarking upon their first full-time 3-month clinical internship. Enrolled participants will be randomized to one of the three groups. The intervention will span 12 weeks and allow for participants to learn about and practice lucid dream induction, stress management, and sleep hygiene in bi-monthly online group sessions and through daily home exercises.

Primary Outcome

The Perceived Stress Scale (PSS) is a 10-item, 6-point, self-report Likert scale (0 = no stress, 5 = high stress) that requires 5 minutes to complete. The scale yields a total score ranging from 0 (no stress) to 50 (highest stress) with scores 25+ indicating a possible stress disorder. The PSS measures stress level in the last month and was intended for use by community-dwelling adults.

Interventions

  • BEHAVIORAL Stress Reduction
  • BEHAVIORAL Lucid Dream
  • BEHAVIORAL Sleep Hygiene Techniques

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2019-06-01
Est. Completion 2019-09-21
Phase NA
Columbia University

958 total trials

What the finished NCT03913988 record still lists

NCT03913988 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 3 interventions - of which Stress Reduction is the first listed.

NCT03913988 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03913988 about?

NCT03913988 is a clinical study titled "Comparative Effectiveness of Three Lucid Dreaming and Sleep Hygiene Techniques". In this study, the investigators will compare traditional lucid dream induction techniques, stress reduction strategies, and sleep hygiene across three study groups: (1) lucid dream and stress reduction techniques, and sleep hygiene; (2) lucid dream reduction and sleep hygiene; and (3) sleep hygiene...

What is the current status of trial NCT03913988?

This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2019-06-01. Estimated completion is 2019-09-21.

What interventions are being tested in trial NCT03913988?

The interventions under investigation include: Stress Reduction (BEHAVIORAL), Lucid Dream (BEHAVIORAL), Sleep Hygiene Techniques (BEHAVIORAL).

Who is sponsoring clinical trial NCT03913988?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03913988's enrollment target sits among peer trials

28 1704th of 2000 higher than 293 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03471117 · 28 participants · Phase 4

    Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients

  • NCT03523975 · 28 participants · Phase 1

    Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma

  • NCT03608631 · 28 participants · Phase 1

    iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation

  • NCT03810651 · 28 participants · Early Phase 1

    Pencil Beam Scanning in Patients With Renal Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03913988, the US trial registry maintained by the National Library of Medicine. NCT03913988 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.